Sex-stratified analysis of the safety of percutaneous left atrial appendage occlusion
- PMID: 33048417
- DOI: 10.1002/ccd.29282
Sex-stratified analysis of the safety of percutaneous left atrial appendage occlusion
Abstract
Objectives and background: There is insufficient current evidence about whether sex impacts outcomes of percutaneous left atrial appendage occlusion (LAAO). The aim of this study was to investigate the association between sex and short-term outcomes of LAAO.
Methods: Patients who were hospitalized and underwent LAAO from October 2015 to December 2017 in the National Readmission Database were queried. The primary endpoint of interest was major in-hospital adverse events. Secondary endpoints included, 30-day readmission rate, nonhome discharge, and cost of hospitalization. Propensity score matching (1:1) was performed to compare the outcomes among women and men.
Results: A total of 9,281 patients were included in the current analysis [women = 3,659 (39%); men = 5,622 (61%)]. Comparing women to men, women had lower prevalence of diabetes mellitus (30.6% vs 35.7%, p < .01), heart failure (28.6% vs 30.8%, p = .03), vascular disease (55.5% vs 69.6%, p < .01) and renal failure (18.3% vs 21.2%, p < .01), and higher CHA2 DS2 VASc score (5 [IQR4-6] vs 4 [IQR3-6], p < .01). After propensity-score matching, women had higher rate of major in-hospital adverse events (2.8% vs 1.9%; p < .01), and nonhome discharges (11.4% vs 6.7%; p < .01). Additionally, 30-day readmission rate was higher among women (10% vs 8.6%, p = .03).
Conclusion: Among hospitalized patients undergoing LAAO, women carry higher risk for major in-hospital adverse events, nonhome discharge, and 30-day readmission rates.
Keywords: female; left atrial appendage occlusion; readmission; sex and gender disparity; women.
© 2021 Wiley Periodicals LLC.
Comment in
-
Gender and left atrial appendage occlusion: Not the exception in cardiovascular procedures.Catheter Cardiovasc Interv. 2021 Apr 1;97(5):893-894. doi: 10.1002/ccd.29667. Catheter Cardiovasc Interv. 2021. PMID: 33851790 No abstract available.
References
REFERENCES
-
- Krijthe BP, Kunst A, Benjamin EJ, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34:2746-2751.
-
- Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119-125.
-
- Alkhouli M, Alqahtani F, Aljohani S, Alvi M, Holmes DR. Burden of Atrial Fibrillation-Associated Ischemic Stroke in the United States. JACC Clin Electrophysiol. 2018;4:618-625.
-
- Alkhouli M, Friedman PA. Ischemic Stroke Risk in Patients With Nonvalvular Atrial Fibrillation: JACC Review Topic of the Week. J Am Coll Cardiol. 2019;74:3050-3065.
-
- Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857-867.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical